Airvo 3 Respiratory Rate Validation Study

Status unconfirmed · Not applicable

Conditions studied: COPD, Healthy Volunteers

In brief

This is a clinical performance testing to validate the accuracy of the Airvo 3 device with respiratory rate algorithm manufactured by Fisher \& Paykel Healthcare for continuous respiratory rate monitoring.

Key facts

Study ID

NCT06329609

Run by

Fisher and Paykel Healthcare

People needed

60

Starts

2024-04-01

Expected to finish

2024-10-01

Last updated by the study team

2024-03-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Group A
• Healthy adults with no known history of respiratory disease
• Ability to provide written informed consent
• Ability to comply with study procedures and duration
• Group B
• Out-patient adults with stable COPD: Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 2 - 4
• Ability to provide written informed consent
• Ability to comply with study procedures and duration

You may not qualify if…

• Pregnancy or lactation
• Inability to tolerate nasal prongs
• History of severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, electrocardiogram (ECG) electrodes, or other medical sensors
• Inability to provide consent
• Participants considered to be medically unsuitable to participate in the trial

Where it is running

• Element Boulder — Louisville, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.